[Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]

Ann Dermatol Venereol. 2011 Mar;138(3):252-8. doi: 10.1016/j.annder.2011.01.017. Epub 2011 Feb 22.
[Article in French]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Biopsy
  • Desmogleins / immunology
  • Humans
  • Immunologic Tests / methods
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Paraneoplastic Syndromes / diagnosis
  • Paraneoplastic Syndromes / drug therapy
  • Patient Care Team
  • Pemphigus / classification
  • Pemphigus / diagnosis*
  • Pemphigus / drug therapy*
  • Pemphigus / pathology
  • Pemphigus / therapy
  • Physical Examination
  • Plakins / immunology

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Autoantibodies
  • Autoantigens
  • Desmogleins
  • Immunosuppressive Agents
  • Plakins